Sign inGet started

Jahr Robert Charles

Insider CIK 2076177 · OTLK Chief Executive Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OTLK Outlook Therapeutics, Inc. P Buy deriv2026-08-142026-08-14151,515— $0151,515SEC↗
OTLK Outlook Therapeutics, Inc. P Buy2026-08-142026-08-14151,515— $0151,515SEC↗
OTLK Outlook Therapeutics, Inc. P Buy deriv2026-08-142026-08-14151,515— —151,515SEC↗
OTLK Outlook Therapeutics, Inc. P Buy2026-08-142026-08-14151,515— —151,515SEC↗
OTLK Outlook Therapeutics, Inc. A Award deriv2026-07-212026-07-23100,000— $0100,000SEC↗
OTLK Outlook Therapeutics, Inc. A Award deriv2025-07-012025-07-09800,000— $0800,000SEC↗